×
Investor Contact Information ... Cellectar Biosciences, Inc. 100 Campus Drive, Suite 207. Florham Park, NJ 07932. T: 608-441-8120 investors@cellectar.com ...
Missing: clrbw | Show results with:clrbw
Investor Tools. Email Alerts · Contacts · RSS News Feed. News / Events. Overview · Press Releases · IR Calendar · Email Alerts. All News, 2024, 2023, 2022, 2021 ...
Missing: clrbw | Show results with:clrbw
The Investor Relations website contains information about Caribou Biosciences, Inc.'s business for stockholders, potential investors, and financial ...
Missing: clrbw | Show results with:clrbw
Aug 20, 2019 · Financial Summary for Cellectar Biosc WT (CLRBW) showing last 5-quarter or 5-year trends for Income Statement, Balance Sheet, and Cash Flow.
Missing: relations | Show results with:relations
Access RBC's financial information, share information, investor events and presentations, earnings calls and more at RBC Investor Relations.
Missing: clrbw | Show results with:clrbw
Mar 20, 2024 · A replay of the call will be available on Events section of the company's investor relations website. About Cellectar Biosciences, Inc ...
... Investor Relations, Public Relations and Corporate Communications and appointed J. Patrick Genn as our Vice President of Business Development. Mr. Genn ...
Find the latest institutional holdings data for Cellectar Biosciences, Inc. Common Stock (CLRB) including shareholders, ownership summaries, ...
Missing: clrbw | Show results with:clrbw
Cellectar Biosciences Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View CLRB financial statements in full.
People also ask
Our lead PDC therapeutic, CLR 131 is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure ...